(Q40117008)

English

Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

based on heuristic

inferred from title

Yoshihito Yokoyama

2

object named as

Yoshihito Yokoyama

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Hideki Mizunuma

5

object named as

Hideki Mizunuma

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

author name string

Bing Xin

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Tatsuhiko Shigeto

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Masayuki Futagami

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

0 references

publication date

1 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

110

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

791-800

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

21 January 2018

Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

21 January 2018

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase-2 expression during carcinogenesis in the human stomach.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Meloxicam inhibits the growth of colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulate angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-1beta-dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22854

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22854

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40117008&oldid=1885749466"